{
  "source": "PubMed",
  "query": "stilbenes",
  "title": "Anticancer efficacy of dual-loaded SLNs with Doxorubicin (DOX) and Pterostilbene (PTS): formulation, characterization, and evaluation for breast cancer.",
  "abstract": "This study aimed to develop optimized doxorubicin (DOX) and pterostilbene (PTS) co-loaded solid lipid nanoparticles (SLNs) for synergistic triple-negative breast cancer (TNBC) therapy, enhancing drug stability, tumor targeting, and therapeutic efficacy.",
  "publication_date": "2025-05-06",
  "journal": "Nanomedicine (London, England)",
  "doi": "10.1080/17435889.2025.2501526",
  "entities": {
    "POLYPHENOL": [
      "pterostilbene"
    ],
    "SYMPTOM": [
      "synergistic triple-negative breast cancer"
    ]
  }
}